PMID- 15896977 OWN - NLM STAT- MEDLINE DCOM- 20060414 LR - 20220705 IS - 1043-6618 (Print) IS - 1043-6618 (Linking) VI - 52 IP - 3 DP - 2005 Sep TI - Ginkgo biloba extract ameliorates ischemia reperfusion-induced renal injury in rats. PG - 216-22 AB - There is increasing evidence to suggest that reactive oxygen metabolites (ROMs) play a role in the pathogenesis of ischemia/reperfusion injury (I/R) in the kidney. This study was designed to determine the possible protective effect of Ginkgo biloba extract (EGb) on renal ischemia/reperfusion (I/R) injury. Wistar albino rats were unilaterally nephrectomized, and 15 days later they were subjected to 45 min of renal pedicle occlusion followed by 6 h of reperfusion. Ginkgo biloba extract (EGb) (50 mg kg(-1) day(-1)) or saline was administered twice, 15 min prior to ischemia and immediately before the reperfusion period. At the end of the treatment period, all rats were decapitated. Kidney samples were taken for histological examination or determination of the renal malondialdehyde (MDA) and glutathione (GSH) levels, myeloperoxidase (MPO) activity and collagen content. Production of reactive oxidants was monitored by chemiluminescence (CL) assay. Creatinine and urea concentrations in blood were measured for the evaluation of renal function. Tumor necrosis factor-alpha (TNF-alpha) and lactate dehydrogenase (LDH) were also assayed in serum samples. Ischemia/reperfusion caused a significant decrease in GSH level, which was accompanied with significant increases in MDA level, MPO activity and collagen content of kidney tissues. Similarly, serum BUN and creatinine levels, as well as LDH and TNF-alpha, were elevated in the I/R group as compared to control group. On the other hand, EGb treatment reversed all these biochemical indices, as well as histopathological alterations, which were induced by I/R. The findings imply that ROMs play a causal role in I/R-induced renal injury and EGb exerts renoprotective effects probably by the radical scavenging and antioxidant activities. FAU - Sener, Goksel AU - Sener G AD - Department of Pharmacology, School of Pharmacy, Marmara University, Tibbiye Cad., 34668 Istanbul, Turkey. gsener@marmara.edu.tr FAU - Sener, Emre AU - Sener E FAU - Sehirli, Ozer AU - Sehirli O FAU - Ogunc, Ayliz Velioglu AU - Ogunc AV FAU - Cetinel, Sule AU - Cetinel S FAU - Gedik, Nursal AU - Gedik N FAU - Sakarcan, Abdullah AU - Sakarcan A LA - eng PT - Journal Article PL - Netherlands TA - Pharmacol Res JT - Pharmacological research JID - 8907422 RN - 0 (Acridines) RN - 0 (Plant Extracts) RN - 0 (Protective Agents) RN - 2315-97-1 (10,10'-dimethyl-9,9'-biacridinium) RN - 4Y8F71G49Q (Malondialdehyde) RN - 5EXP385Q4F (Luminol) RN - 9007-34-5 (Collagen) RN - AYI8EX34EU (Creatinine) RN - EC 1.1.1.27 (L-Lactate Dehydrogenase) RN - EC 1.11.1.7 (Peroxidase) RN - GAN16C9B8O (Glutathione) SB - IM MH - Acridines/metabolism MH - Animals MH - Blood Urea Nitrogen MH - Collagen/metabolism MH - Creatinine/blood MH - Ginkgo biloba/*chemistry MH - Glutathione/metabolism MH - Kidney/drug effects/metabolism/pathology MH - Kidney Diseases/metabolism/pathology/*prevention & control MH - L-Lactate Dehydrogenase/blood MH - Luminol/metabolism MH - Male MH - Malondialdehyde/metabolism MH - Oxidative Stress/drug effects MH - Peroxidase/metabolism MH - Plant Extracts/*pharmacology MH - Protective Agents/*pharmacology MH - Rats MH - Rats, Wistar MH - Reperfusion Injury/metabolism/pathology/*prevention & control EDAT- 2005/05/18 09:00 MHDA- 2006/04/15 09:00 CRDT- 2005/05/18 09:00 PHST- 2005/02/09 00:00 [received] PHST- 2005/03/23 00:00 [revised] PHST- 2005/03/23 00:00 [accepted] PHST- 2005/05/18 09:00 [pubmed] PHST- 2006/04/15 09:00 [medline] PHST- 2005/05/18 09:00 [entrez] AID - S1043-6618(05)00080-0 [pii] AID - 10.1016/j.phrs.2005.03.006 [doi] PST - ppublish SO - Pharmacol Res. 2005 Sep;52(3):216-22. doi: 10.1016/j.phrs.2005.03.006.